My 5-MeO-DMT Psychedelic Experience in Tepotzlan Mexico | Tandava Retreats

In this short vlog, Swati Sharma, Media Director of PsychedelicSpotlight.com recounts her first experience with the psychedelic 5-MeO-DMT.

Like us on Facebook: https://www.facebook.com/PsychedelicSpotlight

To learn more about the emerging psychedelics industry, visit:

Psychedelic Spotlight

To partake in the psychedelic ceremony, Swati traveled to Tandava Retreats in Tepotzlan, Mexico. Was she healed by psychedelics? Did psychedelics help her mental health? What was the experience like? Watch the full video to find out!

In it, she discusses how her “ego death” affected her, and how great the team at Tandava Retreats was.

To learn more about Tandava retreats:
https://tandavaretreats.com/

Tune in to find out more!

Don’t forget to like and subscribe!
#5-MEO-DMT #egodeath #Psychedelics

source

Sarah Abelsohn

Interview With Dr. Hyder A. Khoja

February 3, 2021June 2, 2024 Listen, Podcasts

In this episode, Global Trac Solution’s CEO, David Flores, sits down with Dr. Hyder A. Khoja to learn more about the work they’re doing at Transcendent Therapeutics Inc.

CYBIN CEO Doug Drysdale On How CYB-003 Is Better Than Psilocybin | Next Gen Psychedelics

November 20, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

In this episode of the Spotlight On, James Hallifax from…

Sena Maria On The Benefits of Microdosing

November 24, 2021June 2, 2024 Listen, Microdosing, Podcasts

In this episode, Sena Maria gives us an overview of her Microdosing Activation program and explains some of the benefits of microdosing.

Interview With Nick Levich

March 31, 2021June 2, 2024 Listen, Podcasts

Psychedelic Passage’s Co-Founder and Facilitator, Nick Levich, talks about the function, purpose and importance of a trip sitter during a psychedelic experience.

atai Life Sciences Q2 Conference Call and Questions & Answer Period: BIG NEWS for Psychedelic Stocks

August 16, 2021June 2, 2024 Listen, Videos

What’s up psychedelic stocks investors?!? Today marked atai Life Science’s (Nasdaq: atai) first-ever conference call, for Quarter 2, 2021. In the conference call, atai Life Sciences gave updates on their varying projects, ranging from attempting to treat depression, to cognitive impairment associated with schizophrenia. They also give insights on atai’s digital medicines division and answer investor’s questions at the end of the call.

This Peter Thiel-backed psychedelic therapies company is fighting for the title of the most advanced psychedelic stock. With 10+ different projects under their belt, atai is one of the most exciting companies to keep an eye on in the industry.

This conference call can help investors answer the questions: is atai stock a good investment? Will atai go up? Are psychedelic stocks / shroom stocks good investments? Can psychedelics heal depression? Can psychedelics be used for mental health?

Enjoy the episode!

Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com

Check out our website: thepsychedelicinvestor.com

Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

#atai #ataiLifeSciences #PsychedelicStocks

This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI, FTPRF, ATAI & CYBN]

March 22, 2021June 2, 2024 Listen, Videos

In today’s episode of “This Week in Psychedelic Stocks”, we’ll see some News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin (CYBN) & Fieldtrip Health (FTPRF).

I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the EFSE so that mindmed news is not in this episode.

We will cover the latest developments in the field writ large.
This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.

Timestamps:
0:00 – Intro
0:43 – Australian federal government funds psychedelic research to treat mental illnesses
2:19 – Rhode Island wants to decriminalize all drugs
3:54 – New York Bill to decriminalize psilocybin mushrooms
6:34 – MindMed stock updates ( mmed, mmedf, mmq )
8:17 – Compass Pathways stock news (cmps)
8:49 – Atai Life Sciences news
12:37 – Fieldtrip Health stock news ( ftprf, ftrp)
15:04 – Numinus Wellness stock news ( NUMI, LKYSF)
16:16 – Cybin stock news ( cybn, clxpf)
18:18 General psychedelics discussion

So this is it for This Week in Psychedelic Stocks fellow psychedelic investors!

I hope you guys found some value in this and I’ll keep you posted for more changes!

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

#MindMed #MindmedStock #PsychedelicStocks